Long-term frontal brain metabolic changes in cocaine abusers. 1992

N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
Brookhaven National Laboratory, Upton, New York 11973.

Neurological complications from cocaine use are well recognized. We propose that chronic cocaine use can also cause clinically silent brain dysfunction. We investigated brain glucose metabolism with positron emission tomography (PET) and 2-deoxy-2[18F] fluoro-D-glucose (FDG) in 21 neurologically intact chronic cocaine abusers (C) and 18 normal controls (N). The cocaine abusers were tested 1-6 weeks after the last use of cocaine and seven were retested after a 3 month drug-free period. Global cerebral glucose metabolism was not significantly different between controls and cocaine abusers (N = 38.4 +/- 3, C = 36.5 +/- 5 mumol/100 g of tissue, min). However, cocaine abusers had significantly (P less than 0.05) lower metabolic activity in 16 of the 21 left frontal regions and 8 of the 21 right frontal regions. These decreases persisted after 3-4 months of detoxification and were correlated with the dose (P less than or equal to 0.01) and the years of cocaine use (P less than or equal to 0.05). This study shows reduced rates of frontal metabolism in neurologically intact cocaine abusers that persist even after 3-4 months of detoxification.

UI MeSH Term Description Entries
D008297 Male Males
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D005260 Female Females
D005625 Frontal Lobe The part of the cerebral hemisphere anterior to the central sulcus, and anterior and superior to the lateral sulcus. Brodmann Area 8,Brodmann's Area 8,Frontal Cortex,Frontal Eye Fields,Lobus Frontalis,Supplementary Eye Field,Area 8, Brodmann,Area 8, Brodmann's,Brodmanns Area 8,Cortex, Frontal,Eye Field, Frontal,Eye Field, Supplementary,Eye Fields, Frontal,Frontal Cortices,Frontal Eye Field,Frontal Lobes,Lobe, Frontal,Supplementary Eye Fields
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
December 1988, The American journal of medicine,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
July 1992, Biological psychiatry,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
November 1994, Biological psychiatry,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
September 1990, European journal of pharmacology,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
January 1993, The American journal of drug and alcohol abuse,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
March 1996, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
January 2022, Brazilian journal of otorhinolaryngology,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
December 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
April 2006, The international journal of neuropsychopharmacology,
N D Volkow, and R Hitzemann, and G J Wang, and J S Fowler, and A P Wolf, and S L Dewey, and L Handlesman
July 2010, PloS one,
Copied contents to your clipboard!